(Q44473359)

3 December 2017

title

Antigen loading of dendritic cells with whole tumor cell preparations (English)

1 reference

3 December 2017

1 reference

Peter Thumann

1

1 reference

3 December 2017

Isabelle Moc

2

1 reference

3 December 2017

Jens Humrich

3

1 reference

3 December 2017

Thomas G Berger

4

1 reference

3 December 2017

Erwin S Schultz

5

1 reference

3 December 2017

Gerold Schuler

6

1 reference

3 December 2017

Lars Jenne

7

1 reference

3 December 2017

language of work or name

1 reference

1 June 2003

1 reference

Journal of Immunological Methods

3 December 2017

published in

1 reference

3 December 2017

volume

277

1 reference

3 December 2017

issue

1-2

1 reference

3 December 2017

page(s)

1-16

1 reference

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Dendritic cells as vectors for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Cross-presentation: a general mechanism for CTL immunity and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

A receptor for phosphatidylserine-specific clearance of apoptotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Dendritic cells in cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

The risk of autoimmunity associated with tumor immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Dendritic cells resurrect antigens from dead cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Dendritic cells as adjuvants for immune-mediated resistance to tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

The dendritic cell system and its role in immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Active immunization against cancer with dendritic cells: the near future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Dendritic cell-based immunotherapy of renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

CD4 T cells and their role in antitumor immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Analysis of human transcriptomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Capture and processing of exogenous antigens for presentation on MHC molecules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

Viral immune evasion due to persistence of activated T cells without effector function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2803%2900102-9

10.1016/S0022-1759(03)00102-9

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference